¼¼°èÀÇ ¼ö¼ú¿ë ÁöÇ÷Á¦, ³»ºÎ Á¶Á÷ ½Ç¶õÆ® ¹× À¯Âø ¹æÁöÁ¦ ½ÃÀå
Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers
»óǰÄÚµå : 1564877
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 193 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,301,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,905,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¿Ü°ú¿ë ÁöÇ÷Á¦, ³»ºÎ Á¶Á÷ ½Ç¶õÆ® ¹× Á¢Âø À庮 ¼¼°è ½ÃÀåÀº 2030³â±îÁö 78¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»ó

2023³â 50¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼ö¼ú¿ë ÁöÇ÷Á¦, ³»ºÎ Á¶Á÷ ½Ç¶õÆ® ¹× Á¢Âø À庮 ¼¼°è ½ÃÀåÀº 2023-2030³âÀÇ ºÐ¼® ±â°£ µ¿¾È ¿¬Æò±Õ 6.7% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 78¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ÁöÇ÷Á¦´Â CAGR 7.4%¸¦ ±â·ÏÇÏ¿© ºÐ¼® ±â°£ Á¾·á ½ÃÁ¡¿¡ 36¾ï ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ³»ºÎ Á¶Á÷ ¹ÐºÀÁ¦ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 6.4%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 13¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 11.1%·Î ¼ºÀå Àü¸Á

¹Ì±¹ÀÇ ¼ö¼ú¿ë ÁöÇ÷Á¦, ³»ºÎ Á¶Á÷ ½Ç¶õÆ® ¹× Á¢Âø À庮 ½ÃÀåÀº 2023³â 13¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 19¾ï ´Þ·¯ ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023-2030³âÀÇ ºÐ¼® ±â°£ µ¿¾È 11.1%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ µ¿¾È °¢°¢ 2.8%¿Í 6.6%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ ¿¬Æò±Õ 3.5%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è ¿Ü°ú¿ë ÁöÇ÷Á¦, ³»ºÎ Á¶Á÷ ½Ç¶õÆ® ¹× À¯Âø ¹æÁöÁ¦ ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à

¼ö¼ú¿ë ÁöÇ÷Àç, ü³» Á¶Á÷ ºÀÇÕÀç, Á¢Âø À庮Àº ¿Ö Çö´ë ¼ö¼ú¿¡¼­ Áß¿äÇѰ¡?

¿Ü°ú¿ë ÁöÇ÷Á¦, Á¶Á÷ ³» ºÀÇÕÁ¦, À¯Âø ¹æÁö À庮Àº ÃâÇ÷À» ¾ïÁ¦Çϰí Á¶Á÷À» ºÀÇÕÇÏ¸ç ¼ö¼ú ÈÄ À¯ÂøÀ» ¹æÁöÇϱâ À§ÇØ ¼ö¼ú¿¡ »ç¿ëµÇ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Á¦Ç°µéÀº ½ÉÇ÷°ü ¼ö¼ú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú µî Á¤È®¼º°ú ¾ÈÀü¼ºÀÌ °¡Àå Áß¿äÇÑ º¹ÀâÇÑ ¼ö¼ú¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÁöÇ÷Á¦´Â ¿Ü°ú Àǻ簡 ÃâÇ÷À» ½Å¼ÓÇÏ°Ô Á¦¾îÇÏ°í ¼öÇ÷ÀÇ Çʿ伺À» ÁÙÀ̰í ȯÀÚÀÇ °á°ú¸¦ °³¼±ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ³»ºÎ Á¶Á÷ ½Ç¶õÆ®´Â »óó¿Í Àý°³ ºÎÀ§¸¦ º¸´Ù È¿À²ÀûÀ¸·Î ºÀÇÕÇÏ´Â µ¥ µµ¿òÀÌ µÇ¸ç, Á¢Âø À庮Àº ÇÕº´ÁõÀ» À¯¹ßÇÏ´Â ³»ºÎ ÈäÅÍ Á¶Á÷ÀÇ Çü¼ºÀ» ¹æÁöÇÕ´Ï´Ù. ¿Ü°ú ¼ö¼úÀÌ ´õ¿í Á¤±³Çϰí Àü¹®È­µÊ¿¡ µû¶ó ÀÌ·¯ÇÑ Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ÁöÇ÷Á¦ ¹× Á¶Á÷ ½Ç¶õÆ® ½ÃÀåÀ» º¯È­½ÃŰ´Â Çõ½ÅÀ̶õ?

¿Ü°ú¿ë ÁöÇ÷Á¦ ¹× Á¶Á÷ ½Ç¶õÆ® ½ÃÀåÀº ±Þ¼ÓÇÑ ±â¼ú Çõ½ÅÀ» °Þ°í ÀÖ½À´Ï´Ù. ÀÀ°í ½Ã°£À» ´ÜÃàÇÏ°í ºÎÀÛ¿ëÀ» ÁÙÀΠ÷´Ü ÁöÇ÷Á¦°¡ °³¹ßµÇ¾î ¼ö¼ú Áß ÃâÇ÷À» ´õ Àß Á¦¾îÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. »ýü Èí¼ö¼º ¹× »ýºÐÇØ¼º ½Ç¶õÆ®´Â À̹°ÁúÀ» ü¿Ü·Î Á¦°ÅÇϱâ À§ÇÑ Ãß°¡ °³ÀÔÀÇ Çʿ伺À» ÁÙ¿©Áֱ⠶§¹®¿¡ Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. ÇÕ¼º ¹× »ý¹°ÇÐÀû Á¶Á÷ ½Ç¶õÆ®ÀÇ ±â¼ú Çõ½ÅÀº »ýü ÀûÇÕ¼ºÀ» Çâ»ó½ÃŰ°í °­·ÂÇÑ Á¢Âø·ÂÀ» Á¦°øÇÏ¿© °íÀ§Çè ¼ö¼ú¿¡ ÀÌ»óÀûÀÔ´Ï´Ù. ¶ÇÇÑ, ÃÖ¼Òħ½À ¼ö¼ú¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ º¹°­°æ ¹× ·Îº¿ ¼ö¼ú¿¡ Àû¿ëÇÒ ¼ö Àִ Ư¼ö ½Ç¶õÆ® ¹× Á¢Âø À庮ÀÌ °³¹ßµÇ¾î Á¤È®¼º°ú ȯÀÚ ¾ÈÀü¼ºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù.

¿Ü°ú¿ë ÁöÇ÷Á¦ ¹× Á¶Á÷ ½Ç¶õÆ® »ê¾÷À» ÁÖµµÇÏ´Â ½ÃÀå ¼¼ºÐÈ­´Â?

Á¦Ç° À¯Çü¿¡´Â ±¹¼Ò ÁöÇ÷Á¦, Á¢Âø ½Ç¶õÆ®, ÇÕ¼º Á¢Âø À庮ÀÌ ÀÖÀ¸¸ç, ±¹¼Ò ÁöÇ÷Á¦´Â ÀÏ¹Ý ¿Ü°ú ¼ö¼ú¿¡ ³Î¸® »ç¿ëµÇ¾î °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÕ´Ï´Ù. ¿ëµµº°·Î´Â ½ÉÇ÷°ü ¼ö¼ú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú°¡ ÁÖ¿ä ºÎ¹®ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¼úÀº ÃâÇ÷°ú Á¶Á÷ À¯ÂøÀ» Á¤È®ÇÏ°Ô Á¦¾îÇØ¾ß Çϱ⠶§¹®ÀÔ´Ï´Ù. º´¿øÀÌ ÁÖ¿ä ÃÖÁ¾ »ç¿ëÀÚÀÌÁö¸¸, ÃÖ¼Ò Ä§½À ¼ö¼úÀÌ º¸ÆíÈ­µÊ¿¡ µû¶ó ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)°¡ ºü¸£°Ô ÀÌ Á¦Ç°À» äÅÃÇϰí ÀÖ½À´Ï´Ù. Áö¿ªº°·Î´Â ºÏ¹Ì°¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí À¯·´ÀÌ ±× µÚ¸¦ ÀÕ°í ÀÖÀ¸¸ç, ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÇ·á ÅõÀÚ Áõ°¡·Î ÀÎÇØ ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

¿Ü°ú¿ë ÁöÇ÷Á¦, Á¶Á÷ ½Ç¶õÆ® ¹× À¯Âø ¹æÁöÁ¦ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

¿Ü°ú¿ë ÁöÇ÷Á¦, Á¶Á÷ ³» ºÀÇÕÀç ¹× À¯Âø ¹æÁöÁ¦ ½ÃÀåÀÇ ¼ºÀåÀº Àü ¼¼°è ¼ö¼ú °Ç¼ö Áõ°¡, ÃÖ¼Òħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¼ö¼ú¿ë Á¦Ç°ÀÇ ±â¼ú ¹ßÀü µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ½ÉÇ÷°ü Áúȯ ¹× Á¤Çü¿Ü°ú Áúȯ°ú °°Àº ¸¸¼º ÁúȯÀÇ À¯ÇàÀÌ ÀÌ·¯ÇÑ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, À¯Âø°ú °°Àº ¼ö¼ú ÈÄ ÇÕº´Áõ °¨¼Ò¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ÷´Ü Á¶Á÷ ½Ç¶õÆ® ¹× À¯Âø ¹æÁö À庮ÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ½ÅÈï °æÁ¦±¹ÀÇ ÀÇ·á ÀÎÇÁ¶ó È®´ë¿Í ½ÅÁ¦Ç° ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹½Ã(ÁÖ¸ñ¹Þ´Â 44°³»ç)

  • Axio Biosolutions Private Limited
  • Beacon Senior Advisors
  • Chitogen, Inc.
  • Corlison Pte.
  • Ethicon US LLC
  • GELITA MEDICAL
  • LifeBond Ltd.
  • Tissuemed Ltd.

    ¸ñÂ÷

    Á¦1Àå Á¶»ç ¹æ¹ý

    Á¦2Àå ÁÖ¿ä ¿ä¾à

    • ½ÃÀå °³¿ä
    • ÁÖ¿ä ±â¾÷
    • ½ÃÀå µ¿Çâ°ú ÃËÁø¿äÀÎ
    • ¼¼°è ½ÃÀå Àü¸Á

    Á¦3Àå ½ÃÀå ºÐ¼®

    • ¹Ì±¹
    • ij³ª´Ù
    • ÀϺ»
    • Áß±¹
    • À¯·´
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ¿µ±¹
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • È£ÁÖ
    • Àεµ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿
    • À̶õ
    • À̽º¶ó¿¤
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • ±âŸ Áßµ¿
    • ¾ÆÇÁ¸®Ä«

    Á¦4Àå °æÀï

    LSH
  • ¿µ¹® ¸ñÂ÷

    ¿µ¹®¸ñÂ÷

    Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market to Reach US$7.8 Billion by 2030

    The global market for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers estimated at US$5.0 Billion in the year 2023, is expected to reach US$7.8 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2023-2030. Hemostats, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$3.6 Billion by the end of the analysis period. Growth in the Internal Tissue Sealants segment is estimated at 6.4% CAGR over the analysis period.

    The U.S. Market is Estimated at US$1.3 Billion While China is Forecast to Grow at 11.1% CAGR

    The Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers market in the U.S. is estimated at US$1.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2030 trailing a CAGR of 11.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.8% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

    Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market - Key Trends and Drivers Summarized

    Why Are Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Critical in Modern Surgery?

    Surgical hemostats, internal tissue sealants, and adhesion barriers are crucial tools used in surgeries to control bleeding, seal tissues, and prevent postoperative adhesions. These products are widely utilized in complex surgeries such as cardiovascular, orthopedic, and neurosurgical procedures, where precision and safety are paramount. Hemostats help surgeons control bleeding rapidly, reducing the need for blood transfusions and improving patient outcomes. Internal tissue sealants aid in closing wounds or incisions more efficiently, while adhesion barriers prevent the formation of internal scar tissue, which can lead to complications. As surgical procedures become more advanced and specialized, the demand for these products has significantly increased.

    What Innovations Are Transforming the Hemostats and Tissue Sealants Market?

    The market for surgical hemostats and tissue sealants is experiencing rapid innovation. Advanced hemostats with faster coagulation times and reduced side effects are being developed, offering better control over bleeding during surgeries. Bioabsorbable and biodegradable sealants are gaining traction as they reduce the need for additional interventions to remove foreign materials from the body. Innovations in synthetic and biologic tissue sealants provide enhanced biocompatibility and stronger adhesion, making them ideal for high-risk surgeries. Furthermore, the growing focus on minimally invasive surgeries has led to the development of specialized sealants and adhesion barriers that can be applied via laparoscopic or robotic techniques, offering enhanced precision and patient safety.

    Which Market Segments Are Leading in the Surgical Hemostats and Tissue Sealants Industry?

    Product types include topical hemostats, adhesive sealants, and synthetic adhesion barriers, with topical hemostats holding the largest market share due to their widespread use in general surgeries. In terms of application, cardiovascular, orthopedic, and neurosurgery are the leading segments, as these procedures require precise control over bleeding and tissue adhesion. Hospitals dominate as the primary end-users, although ambulatory surgery centers are rapidly adopting these products as minimally invasive surgeries become more common. Geographically, North America holds the largest market share, followed by Europe, while the Asia-Pacific region is witnessing rapid growth due to increasing healthcare investments.

    What Drives Growth in the Surgical Hemostats, Tissue Sealants, and Adhesion Barriers Market?

    The growth in the surgical hemostats, internal tissue sealants, and adhesion barriers market is driven by several factors, including the rising number of surgeries worldwide, increasing demand for minimally invasive procedures, and technological advancements in surgical products. The prevalence of chronic diseases such as cardiovascular and orthopedic conditions is fueling the demand for these solutions. Additionally, the growing focus on reducing postoperative complications, such as adhesions, is propelling the adoption of advanced tissue sealants and adhesion barriers. The expansion of healthcare infrastructure in emerging economies, along with increasing investments in research and development for new products, is further contributing to market growth.

    Select Competitors (Total 44 Featured) -

    TABLE OF CONTENTS

    I. METHODOLOGY

    II. EXECUTIVE SUMMARY

    III. MARKET ANALYSIS

    IV. COMPETITION

    (ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
    ¨Ï Copyright Global Information, Inc. All rights reserved.
    PC¹öÀü º¸±â